FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02808481

Enrollment

Registered

2016-06-21

Start date

2016-06-30

Completion date

2016-12-31

Last updated

2016-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Keywords

systemic sclerosis, cardiac disease, Heart transplantation, primitive cardiac damage

Brief summary

Systemic sclerosis is a rare disease. The early cardiac disease affects 10% of patients sclérodemiques. Heart transplantation in the early cardiac involvement in systemic sclerosis is exceptional. we see patient data analysis with systemic sclerosis who used cardiac transplantation to understand the primitive cardiac damage associated with systemic sclerosis

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients meet the criteria for classification of systemic sclerosis * Adverse primitive heart that required a heart transplant * Patients who have given their verbal agreement to use their data for research purposes.

Exclusion criteria

* Localized Scleroderma or sclerodermiform syndrome * Heart disease secondary to pulmonary or renal impairment * Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Analysis of data from patients with systemic sclerosis who used cardiac transplantation for primary cardiac involvement	1month post-transplantation

Contacts

Primary ContactEmmanuel CHATELUS, MD

emmanuel.chatelus@chru-strasbourg.fr33 (0)3.88.12.81.15

Outcome results